Introduction {#sec1-1}
============

There is a demand in the life sciences for a constant supply of highly differentiated cell types such as cardiomyocytes, hepatocytes, endothelial cells, and neuronal cells that often show a limited life span, minimal proliferation capacity, and rapid de-differentiation in primary cell culture. For primary human cardiomyocytes, there is practically no supply since healthy organs are rarely available and the cells quickly expire without perfusion. Embryonic stem cells (ESC) originating from the blastocyst stage of early human embryos raise ethical questions and cannot be obtained from the same patient for cell therapies. The few immortalized cardiomyocyte cell lines that are commercially available are of animal origin and provide little advantage over primary cardiomyocytes from neonatal rodents. However, since the first publication in 2006 with murine and 2007 with human cells by Yamanaka *et al*.,^[@ref1]^ so-called induced pluripotent stem cells (iPSC) have rapidly become a popular tool. Cells differentiated from iPSC appear as a valid alternative to primary cells for laboratory studies, drug development, and regenerative medicine. In the last few years, there have been considerable advances in the methods of 're-programming' somatic cells to iPSCs using non-viral transfection and genome editing.^[@ref2]^ Subsequently, these cells can be used to produce differentiated human cell types such as cardiomyocytes (hiPSC-CMs) using established protocols.^[@ref3],[@ref4]^ Existing applications of hiPSC-CMs include drug safety testing, disease modeling, and tissue engineering. ^[@ref2],[@ref5]^With this method, it is possible to obtain cells from adult patients with cardiac disorders, with a well-documented disease and family history, to study the resulting cellular phenotype in detail. Additionally, hiPSC-derived cell types can be genetically modified, for example, to test a gene therapy approach *in vitro* demonstrating the attempted rescue in a relevant genetic setting. A remaining concern with hiPSC-CMs is their reportedly immature developmental status and diverse phenotypes.^[@ref6],[@ref7]^

We have investigated several cellular features in commercially available hiPSCCMs by immunocytochemistry and confocal microscopy to characterize this type of model system for future use in toxicology and basic research. For some selected proteins, we have compared expression and organization with freshly isolated, adult cardiomyocytes. This study provides a 'snapshot' of several cytoskeleton proteins of this cell type in culture. We did not attempt to improve maturation of the cells outside of culturing for ten days to replicate a typical experimental situation where the non-proliferating cells are used from frozen stock, treated with test compounds, and analyzed.

Materials and Methods {#sec1-2}
=====================

Cell culture {#sec2-1}
------------

Human iPSC-derived cardiomyocytes (hiPSC-CMs, ax2505) were obtained from Axol Bioscience (Little Chesterford, Cambridge, UK). The original hiPSC cell line was produced using an episomal vector and CD34+ cord blood cells from a male newborn donor. Cryopreserved cardiomyocytes were rapidly thawed, then diluted in maintenance medium with supplements (Axol Bioscience, ax2530) and 10% fetal bovine serum. The cells were then seeded into dishes with a glass-bottom well of 10 mm diameter (MatTek, Ashland, MA, USA) coated with 1% gelatin in water (Sigma- Aldrich, St. Louis, MO, USA; G1393). After 48 h, plating medium was exchanged with maintenance medium without serum for the first time, and then changed every two days.

Immunocytochemistry of cultured cells and confocal microscopy {#sec2-2}
-------------------------------------------------------------

Cells cultured for 10 days on glass-bottom dishes (MatTek) were washed with phosphate buffered saline (PBS) then fixed with 3% para-formaldehyde in PBS for 15 min, permeabilized with 0.2% Triton-X100 (Sigma-Aldrich) in PBS for 10 min, incubated for 30 min with bovine serum albumin (Sigma-Aldrich) 1 mg/mL in PBS at room temperature, incubated overnight with primary antibodies at 4°C, washed 3 times with PBS and incubated for 1 h with secondary antibodies goat anti-rabbit or goat antimouse coupled to AlexaFluor488 or AlexaFluor546 fluorescent dyes (Thermofisher Scientific/Molecular Probes, Waltham, MA, USA) at room temperature in the dark. Primary antibodies used in this study are listed in [Table 1](#table001){ref-type="table"}. Antibodies to embryonic heart myomesin (EH-myomesin) and M-protein were a kind gift from Dr. Irina Agarkova (Federal Institute of Technology, ETHZ, Zurich, Switzerland). Preparations were embedded using non-hardening solutions with anti-fading protection with or without DAPI (SlowFade Diamond, Invitrogen, Carlsbad, CA, USA; or Vectashield/DAPI, Vector Laboratories, Burlingame, CA, USA). Preparations were examined with a Zeiss LSM 710 confocal microscope using EC Plan-Neofluar 40x/1.30 and Plan-Apochromat 60x/1.40 oil immersion lenses (Carl Zeiss, Oberkochen, Germany). Manual counting of the respective fraction of cells showing protein expression and sarcomeric organization was conducted using at least 200 cells from multiple fields of confocal images from 3 independent immunocytochemistry experiments and different batches of hiPSC-CMs. Measurement of morphologic features was performed using the software NIH-ImageJ (U.S. National Institutes of Health and available on the Internet at <http://rsb.> info.nih.gov/nihimage/) on confocal images obtained from cardiomyocytes immunostained for the sarcomeric M-line marker myomesin. A lineprofile was created along the myofibril and distances between peaks were measured. Only cells at resting length were evaluated. For the form factor, maximum lengths and widths of cells in low-density cultures were measured and expressed as a ratio. At least ten images showing several cells were used for the analysis of each feature and the data were statistically analyzed using the twotailed Student's *t*-test (Graphpad Prism).

Isolation of adult rat cardiomyocytes and immunocytochemistry {#sec2-3}
-------------------------------------------------------------

Adult rat ventricular cardiomyocytes (ARVM) were isolated as previously described^[@ref8],[@ref9]^ from 3 months old (350-400 g) male Wistar rats, seeded onto gelatine-coated chamber slides and immediately fixed with 4% p-formaldehyde in PBS for 20 minutes. The preparations were permeabilized with 1% Triton-X100 (Sigma-Aldrich) in PBS for 20 min, incubated for 1 h with bovine serum albumin (Sigma-Aldrich) 1 mg/mL in PBS at room temperature, incubated overnight with primary antibodies at 4°C, washed 3 times with PBS and incubated 2 h with secondary antibodies coupled to Alexa fluorescent dyes (Thermofisher/ Molecular Probes) at room temperature. Preparations were then washed, embedded and examined as described for the hiPSCCMs. Only primary antibodies equally recognizing both human and rodent protein isoforms were selected for this experiment. All experiments were carried out according to the Swiss animal protection law and with the permission of the canton Bern veterinary office (license BE32/14). This investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Results {#sec1-3}
=======

Cytoskeleton and sarcomeric proteins {#sec2-4}
------------------------------------

Cryopreserved hiPSC-CMs were thawed and cultured for ten days as described in the materials and methods section. The cells were then fixed and immunostained for several cytoskeleton and sarcomeric proteins ([Figure 1](#fig001){ref-type="fig"}). In several co-stainings, a well-described marker of the sarcomeric M-line, myomesin,^[@ref10],[@ref11]^ served to demonstrate cellular identity and myofibrillar content in the cultured cells ([Figure 1](#fig001){ref-type="fig"} C2, E1 and [Figure 2](#fig002){ref-type="fig"} C2,D2,E2). Essential muscle proteins comprise the family of myosin heavy chains. Their increase in expression has been used as a cardiogenic marker in early embryonic development.^[@ref12]^ Immunolabeling of alpha- or beta-myosin heavy chain proteins resulted in a nearly identical pattern that only slightly varied in intensity between cells ([Figure 1A](#fig001){ref-type="fig"}). The myosin heavy chain isoforms were also found in the freshly isolated ARVM ([Figure 3F](#fig003){ref-type="fig"}). Two myosin light chain isoforms have been described as ventricular and atrial-specific proteins in the adult heart (MLC2v, MLC2a).^[@ref13]^ We have found hiPSC-CMs expressing either one of these myosin light chain isoforms or both, to a different extent in the cultures ([Figures 1B](#fig001){ref-type="fig"} and 4A). As demonstrated by the immunostaining of freshly isolated cells from adult rats, the atrial-specific isoform MLC2a does not occur in ARVM ([Figure 3A](#fig003){ref-type="fig"}). Desmin, the predominant intermediate filament protein in striated muscle, has previously been demonstrated in hiPSC-CMs and ARVM in our lab.^[@ref14],[@ref15]^ Vimentin is an intermediate filament protein that is expressed in fetal cardiomyocytes and in non-myocytes in adult tissue and was reported to disappear from cardiomyocytes postnatally.^[@ref16]^ Here we have stained the cells for vimentin, and for myomesin to identify cardiomyocytes ([Figure 1C](#fig001){ref-type="fig"}). Vimentin-positive filaments were found in virtually all hiPSC-CMs in the culture, but not in freshly isolated ARVM ([Figure 3C](#fig003){ref-type="fig"}). In contrast to vimentin, desmin was observed only in a fraction of the cultured cells (*not shown*, for quantification see [Figure 4A](#fig004){ref-type="fig"}). The Z-line marker protein sarcomeric alpha-actinin was found in all hiPSC-CMs and was organized in sarcomeres ([Figure 1D](#fig001){ref-type="fig"}). Microtubules were observed in all hiPSC-CMs in culture ([Figure 1D](#fig001){ref-type="fig"}). The distribution pattern of microtubules was not correlated with other cytoskeleton elements as previously observed in cultured adult rat cardiomyocytes. ^[@ref17]^

Cell-cell contact proteins {#sec2-5}
--------------------------

We observed prominent labeling of adherens junction, desmosomal and gap junction proteins at cell-cell contacts in the cultured hiPSC-CMs ([Figure 2](#fig002){ref-type="fig"} A,B). Betacatenin- positive junctions occurred at all cell-cell contacts in the monolayer culture ([Figure 2A](#fig002){ref-type="fig"}). Connexin-43 was found in the form of gap junction plaques and a perinuclear distribution, as has previously been observed in other cardiomyocyte *in vitro* models.^[@ref18]^ Junctions positive for N-cadherin were found at cell-cell contacts partially colocalizing with desmoglein-2, a typical marker of desmosomes^[@ref19]^ ([Figure 2B](#fig002){ref-type="fig"}). Immunostaining freshly isolated ARVM for N-cadherin demonstrated the strictly polarized localization of adherens junctions at the ends of the rod-shaped cells, the intercalated discs ([Figure 3G](#fig003){ref-type="fig"}). We also investigated proteins of the so-called costamer complex that provides mechanical anchorage linking Zdiscs of sarcomeres *via* integrins to laminin and other extracellular matrix proteins along the long axis of the cells in tissue.^[@ref20]^ In the cultured hiPSC-CMs, laminin was found to enclose cultured cardiomyocytes ([Figure 1E](#fig001){ref-type="fig"}), but no striated pattern along Z-discs was observed as it is present in the freshly isolated cardiomyocytes immunostained for laminin ([Figure 3H](#fig003){ref-type="fig"}).

Calcium-handling proteins {#sec2-6}
-------------------------

Calcium-handling proteins are part of the excitation-contraction machinery of cardiomyocytes and are therefore of great interest for disease models and drug screening. Labeling of bridging integrator-1 (bin- 1), a membrane scaffolding protein that is essential for the formation of T-tubules and their efficient function,^[@ref21]^ showed bin 1 positive ladders and striation along myofibrils ([Figure 2C](#fig002){ref-type="fig"}). Immunostaining of hiPSCCMs for sarcoplasmic reticulum ATPase2a (SERCA2a) showed labeling in virtually all cells, although a striated pattern of the staining was mainly visible in elongated features with linear myofibrils ([Figure 2D](#fig002){ref-type="fig"}). Immunolabeling for ryanodine receptors (RyR) showed the protein in all cells, although the level of organization differed in the cell population ([Figure 2E](#fig002){ref-type="fig"}). The immunostaining of freshly isolated ARVM for junctophilin-2, a protein that is essential for the structural organization of the above mentioned sarcoplasmic reticulum/ryanodine- complex of calcium-handling proteins, ^[@ref22]^ showed a striated pattern along the long axis of the cells ([Figure 3H](#fig003){ref-type="fig"}).

Developmentally regulated proteins {#sec2-7}
----------------------------------

In the following, we report about sarcomeric proteins that are known to undergo an isoform switch from fetal to the adult human myocardium or to show increasing levels of structural organization during development of the heart. We have investigated immunolabeled hiPSC-CMs ([Figure 5](#fig005){ref-type="fig"}) and performed counting of the observed phenotypes ([Figure 4A](#fig004){ref-type="fig"}). Telethonin (also known as T-cap) was described as a signaling and mechano-sensitive element in the heart.^[@ref23],[@ref24]^ We have found a generally intense telethonin labeling of hiPSC-CMs in the 10-day old culture, although a sarcomeric striation pattern in the telethoninchannel was only visible in few places ([Figures 4A](#fig004){ref-type="fig"} and 5A) that included myofibrils as demonstrated by the actin ([Figure 5](#fig005){ref-type="fig"} A2) or myomesin labeling ([Figure 1B](#fig001){ref-type="fig"}). Cardiac ankyrin repeat protein (CARP) (also known as cardiac-adriamycin-responsive protein or ankyrin repeat domain-1, ANKRD1) was found in the culture and showed a striation pattern in a sub-population ([Figures 4A](#fig004){ref-type="fig"} and 5B). Additionally, a nuclear localization of CARP in hiPSCCMs has been noted ([Figure 5](#fig005){ref-type="fig"} B1), as it has been described previously in primary cardiomyocytes. ^[@ref25],[@ref26]^ In the freshly isolated adult cardiomyocytes, CARP was observed in all cells showing a distinct I-band striation pattern ([Figure 3D](#fig003){ref-type="fig"}). Troponin-I isoforms have been reported to represent good markers for cardiomyocyte maturation because of the switch that occurs during development from the fetal form of slow skeletal TnI to the adult cardiac TnI.^[@ref27]^ We have used an antibody for the adult cardiac troponin-I isoform ([Table 1](#table001){ref-type="table"}) and found a patchy expression in the hiPSC-CM culture ([Figures 4A](#fig004){ref-type="fig"} and 5C). That image shows a group of cells positive for troponin-I, but also at least one cardiomyocyte in the lower part of the image, that does not show any apparent labeling ([Figure 5](#fig005){ref-type="fig"} C1). Cardiac troponin-T was found in all hiPSC-CMs in sarcomeric organization (*not shown*). Some sarcomeric and cytoskeleton proteins have been observed to re-appear in diseases of the adult heart as part of an adaptation and remodeling process of the myocardium. An example for this type of proteins is alpha-smooth muscle actin, that is only expressed in smooth muscle cells of the vasculature in the normal adult heart, but is found in the myocardium in patients with pathological cardiac hypertrophy.^[@ref28]^ In the hiPSC-CMS we found a patchy distribution of cells expressing alpha-smooth muscle actin ([Figures 4A](#fig004){ref-type="fig"} and 5D). Cardiomyocytes were identified by sarcomeric striation in the all-actin image ([Figure 5](#fig005){ref-type="fig"} D2).

Freshly isolated ventricular rat Cardiomyocytes {#sec2-8}
-----------------------------------------------

Freshly isolated ventricular cardiomyocytes (ARVM) from healthy adult rats provide *bona fide* examples for the fully differentiated endpoint of cytoskeleton and sarcomeric development in the mammalian heart. We have used ARVM for immunocytochemistry of selected proteins that had been previously investigated in the cultured hiPSC-CMs ([Figure 3](#fig003){ref-type="fig"}). The same antibodies were used as for the hiPSC-CMs. Generally, immunolabeling was uniform in the population of isolated ARVM unlike the patchy, cell-autonomous distribution seen for some proteins in the cultured hiPSCCMs. The results confirmed the specificity of the myosin light chain 2a antibodies that do not label ARVM ([Figure 3A](#fig003){ref-type="fig"}). The labeling of telethonin showed a well-organized, distinct sarcomeric pattern for the titinbinding protein ([Figure 3B](#fig003){ref-type="fig"}). The immunolabeling for cardiac troponin-T and vimentin confirmed, that vimentin is absent from adult ventricular cardiomyocytes ([Figure 3C](#fig003){ref-type="fig"}). The labeling of CARP showed a distinct sarcomeric pattern ([Figure 3D](#fig003){ref-type="fig"}). In fetal heart cardiomyocytes, all M-lines contain embryonic-heart myomesin (EHmyomesin), while this isoform is strongly down-regulated after birth.^[@ref29]^ On the other hand, M-protein is a typical protein of the adult M-line^[@ref30]^ as was confirmed here in ARVM ([Figure 3E](#fig003){ref-type="fig"}). EH-myomesin was consistently found in all cultured hiPSCCMs ([Figure 2](#fig002){ref-type="fig"} C,D), but not in freshly isolated ARVM ([Figure 3E](#fig003){ref-type="fig"}).

Quantification of immunolabeling and sarcomeric organization {#sec2-9}
------------------------------------------------------------

A manual quantification was performed on populations of cells that showed either incomplete sarcomeric organization as was the case for telethonin (in 9.4% of all cells organized in sarcomers) and CARP (organized in 32%), or showed a patchy distribution of expression such as observed for cardiac troponin-I (found in 19% cells), alphasmooth muscle actin (in 23% cells), desmin (in 9.9% cells), and the atrial/ventricular light chain isoforms (72% MLC2v *vs* 25% MLC2a) ([Figure 4A](#fig004){ref-type="fig"}). The quantitative assessment of morphological features can be instrumental to identify the maturation stage of cardiomyocytes^[@ref7]^ and therefore we evaluated sarcomere length and the overall shape of the cells in hiPSC-CMs compared to ARVM. The analysis of sarcomere length in cultured hiPSC-CMs compared to freshly isolated ARVM showed a significant difference between the two cell types ([Figure 4B](#fig004){ref-type="fig"}) with a value of 1.7±0.13 μm for hiPSCCMs and 1.9±0.09 for ARVM (n=40, P\<0.001). The form factor, *i.e*. the ratio of cell length divided by the width, demonstrates the extent of elongation ([Figure 4C](#fig004){ref-type="fig"}). This parameter showed a significant difference between the cells, although there was a considerable amount of variability observed. The ratio was measured as 2.9±1.7 for hiPSC-CMs and 5.7±1.3 in ARVM (n=17, P\<0.001).

Discussion {#sec1-4}
==========

As iPSC-derived cells are growing in popularity in recent years for both basic research and drug development, there is a need for a thorough characterization and validation of these new tools. Still, questions are raised about the general limitations of iPSC-derived cardiomyocytes as compared to more traditional models.^[@ref31]^ In principle, all investigations published so far on the core properties of hiPSC-CMs have found typical features of cardiac muscle. The remaining issues are the immaturity of the cells and the resulting differences in gene expression when compared to the adult human heart. Also, considerable heterogeneity between production lots and within the cell population regarding cardiomyocyte subtypes has been observed.^[@ref2]^ For complex *in vitro* model systems with multiple cell types or tissue-like 3D-culture systems and tissue engineering approaches, survival, stability, and development over longer periods of time in culture are relevant. ^[@ref14],[@ref32]^ These cytoskeleton markers and the corresponding immunoreagents that we have evaluated in this study provide effective tools for future investigations to assess the maturation status of tissue constructs, especially in the field of tissue engineering where the integration of the tissue in a fully developed host environment is crucial. Although a variety of techniques for characterizing hiPSC-CM has already been employed so far, immunocytochemistry provides a rapid and straightforward tool to obtain information both on the protein expression and differentiation level of cellular features.

We have tested proteins that are either known to become organized later in development or represent associated proteins that may serve as signaling or mechano-sensitive elements. The intermediate filament proteins desmin and vimentin are both expressed in the embryonal and postnatal heart, but only desmin remains as the characteristic intermediate protein of both striated and smooth muscle in the adult.^[@ref16]^ The sarcomeric M-line protein myomesin serves as a bona fide marker for myofibrils and genuine cardiomyocytes in our experiments, although by electron microscopy, electron-dense M-lines as a further sign of maturation have not yet been found in standard cultures of hiPSC-CMs.^[@ref3]^ Regarding the regulatory myosin light chain proteins it has been reported, that almost all early hiPSC-CM's express MLC2a, and then at later time-points, the MLC2v expressing population becomes predominant, although some cells still expressed or co-expressed MLC2a^[@ref13]^ (and personal observations). All hiPSC-CMs were positive for cardiac troponin- T (cTnT) and the labeling was equal in the entire cell population (*not shown*). Regarding troponin-I, expression from the fetal *TNNI1* gene (ssTnI) is completely replaced in the adult heart by *TNNI3* (cTnI).^[@ref33]^ In cultured hiPSC-CMs, cTnI labeling demonstrated different levels in the culture with some cells showing no labeling at all, while others are strongly stained. Similarly, CARP labeling showed a patchy distribution, however with a distinctly visible sarcomeric structure in strongly expressing cells. CARP is sensitive to cardiotoxic cancer therapies and it is upregulated in left ventricular heart failure,^[@ref34]^ but it is also normally expressed in cardiomyocytes. Alpha smooth muscle actin (aSMA) is expressed in the fetal and postnatal heart.^[@ref28]^ A different picture was observed in telethonin-labeled cells. It has been proposed that telethonin (T-cap) is important for the maturation of sarcomeres, for sensing biomechanical stress, and that its expression rapidly reacts to stimuli that lead to muscular atrophy or growth.^[@ref32],[@ref35]^ Although the signal was generally intense in all hiPSC-CMs, a distinct sarcomeric pattern was visible only in some places, suggesting a robust expression of telethonin but incomplete organization of the protein into sarcomeres. These cytoskeleton proteins discussed above may become instrumental in the assessment of maturation in cardiac *in vitro* models, since these proteins demonstrate stages of a progression. Calcium handling proteins such as the sodium-calcium exchanger and ryanodine receptor have been detected in hiPSC-CMs previously by Western blotting in our laboratory.^[@ref14]^

Bin-1 is a membrane scaffolding protein in cardiomyocytes involved in the trafficking of calcium-handling proteins to the Ttubules via microtubules.^[@ref21]^ Its localization in an I band-associated pattern in the hiPSC-CMs suggests that it is either forming early T-tubules or a precursor protein complex. Intercalated disc proteins in the adult tissue are restricted to the ends of the cylindrical cardiomyocytes.^[@ref36]^ The pattern of adherens and gap junctions as well as desmosomes observed here in hiPSC-CMs appeared similar compared to other culture models of cultured cardiomyocytes.^[@ref18]^ It is therefore unlikely, that cell contact proteins are the first choice for measuring maturation of cardiomyocyte models unless the geometry of the cells could be modified to such extent that the strict polarization seen in tissue reappears. In addition to immunocytochemistry, additional methods such as evaluation of morphological parameters, protein biochemistry and gene expression studies will complete the toolbox for the development of improved i*n vitro* models.

In conclusion, all proteins that are known to be expressed in primary cardiomyocytes have been found in the hiPSC-CMs on day 10 in culture, identifying them as genuine cardiomyocytes. However, the expression pattern and patchy distribution of some proteins suggest that the cell population is still developing. A summary of the qualitative assessment of expression and organization of the investigated proteins is presented in [Table 2](#table002){ref-type="table"}.
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![Cytoskeleton and sarcomeric proteins. Overlay images including DAPI are shown on the left, followed by corresponding green and red channel images in greyscale. A) Cells were immunostained for alpha-MHC (green), beta-MHC (red) and DNA (blue). B) Cells were immunostained for MLC2v (green), MLC2a (red) and DNA (blue). Cells expressing both isoforms appear in orange-yellow. C) Cells were immunostained for vimentin (green), myomesin (red) and DNA (blue). D) Cells were immunostained for alpha-tubulin (green), sarcomeric alpha-actinin (red) and DNA (blue). E) Cells were immunostained for myomesin (green), laminin (red) and DNA (blue).](ejh-61-2-2763-g001){#fig001}

![Junctional proteins and proteins involved in calcium handling. Overlay images including DAPI are shown on the left, followed by corresponding green and red channel images in greyscale. A) Cells were immunostained for beta-catenin (green), connexin-43 (red) and DNA (blue). B) Cells were immunostained for N-cadherin (green), desmoglein- 2 (red) and DNA (blue). C) Cells were immunostained for BIN-1/amphiphysin-2 (green) and EH-myomesin (red). D) Cells were immunostained for SERCA-2a (green), EHmyomesin (red) and DNA (blue). E) Cells were immunostained for ryanodine receptors (green), EH-myomesin (red) and DNA (blue).](ejh-61-2-2763-g002){#fig002}

![Freshly isolated ARVM were immediately fixed and immunostained for the indicated proteins. A-H) Overlay images of single optical sections are shown in color, some including DAPI staining for DNA in blue, followed by separate images in greyscale with the green channel in the middle and red channel on the right.](ejh-61-2-2763-g003){#fig003}

![Quantification of immunolabeling and sarcomeric organization found only in a fraction of the cell population, and sarcomere length and form factor in hiPSC-CMs *vs* adult rat ventricular cardiomyocytes. A) Multiple optical fields from three independent immunocytochemistry experiments were evaluated and results are displayed as parts of a whole (total number of cells evaluated). Actin and vimentin were seen in all cells, while the indicated smaller fraction showed additional proteins/features. B,C) The scatter plots show mean and standard deviation, n=A40/B17 cells, \*\*\*P\<0.001. B) Comparison of sarcomere lengths in hiPSC-CM *vs* freshly isolated ARVM. C) Comparison of length-width ratio (form factor) in cultured hiPSC-CM *vs* freshly isolated ARVM.](ejh-61-2-2763-g004){#fig004}

![Developmentally regulated sarcomeric proteins. Overlay images including DAPI are shown on the left, followed by corresponding green and red channel images in greyscale. Images A and B were taken at higher magnification to resolve individual sarcomers, while C and D show larger groups of cells, where labelled proteins appeared in a sub-population of cells. A) Cells were immunostained for telethonin (green), all actin (red), and DNA (blue); arrows point at foci of sarcomeric organization. B) Cells were immunostained for CARP (green), all actin (red), and DNA (blue). C) Cells were immunostained for cardiac troponin-I (green), all actin (red), and DNA (blue); the arrow points at a cardiomyocyte negative for troponin-I. All actin labeled all the cells (C2). D) Cells were immunostained for alpha-smooth muscle actin (green) and all actin (red); the arrow points at a cardiomyocyte negative for alpha-smooth muscle actin and showing sarcomeric striation in the actin channel; actin was observed in all cells (D2).](ejh-61-2-2763-g005){#fig005}

###### 

Antibodies used in this study.

  Target protein                                  Host     Vendor, clone, article number
  ----------------------------------------------- -------- --------------------------------------------------------------------------------
  All actin                                       Rabbit   Sigma-Aldrich, A2066
  Alpha smooth muscle actin (ACTA2)               Mouse    Abcam (Cambridge, UK), clone 1A4, ab7817
  Alpha-myosin heavy chain (MYH6)                 Rabbit   LifeSpan BioSciences (Seattle, WA, USA), LS-C411049
  Alpha-tubulin                                   Rabbit   GeneTex (Irvine, CA, USA), GTX112141
  Beta-catenin                                    Mouse    Affymetrix eBiosciences (Santa Clara, CA, USA), clone 15B8, 14-2567-80
  Beta-myosin heavy chain (MYH7)                  Mouse    LifeSpan BioSciences, clone IML-64, LS-C312448
  BIN-1/amphiphysin-2                             Mouse    Santa Cruz Biotechnology (Dallas, TX, USA), clone 2F11, sc-23918
  Cardiac ankyrin repeat protein (CARP, ANKRD1)   Mouse    Santa Cruz Biotechnology, clone G2, sc-365056
  Cardiac troponin-I (cTnI, TNNI3)                Mouse    Thermofisher, clone 4C2, MA1-20116
  Cardiac troponin-T (cTnT, TNNT2)                Mouse    Thermofisher, clone 13-11, MA5-12960
  Connexin-43 (GJA1)                              Rabbit   Abcam, ab11370
  Desmin                                          Mouse    LifeSpan BioSciences, LS-B3122-50
  Desmoglein-2                                    Mouse    Abcam, clone 3G132, ab14415
  Embryonic-heart myomesin (EH-myomesin)          Rabbit   Received as gift28,29
  Junctophilin-2                                  Mouse    Santa Cruz Biotechnology, clone H-3, sc-377086
  Laminin                                         Rabbit   Sigma-Aldrich, L9393
  M-protein                                       Mouse    clone AA259, received as gift29,30
  Myomesin (all isoforms)                         Mouse    Developmental Studies Hybridoma Bank, University of Iowa, clone B411
  Myosin light chain 2v (MLC2v)                   Rabbit   Synaptic Systems (Göttingen, Germany), 310203
  Myosin light chain-2a (MLC2a)                   Mouse    Synaptic Systems, clone 56F5, 311011
  N-cadherin                                      Rabbit   Santa Cruz Biotechnology, sc-7939
  Ryanodine receptor                              Mouse    Santa Cruz Biotechnology, clone F-1, sc-376507
  Sarcomeric alpha-actinin                        Mouse    Abcam, clone EA-53
  SERCA2a                                         Mouse    Abcam, clone 2A7-A1, ab2861
  Telethonin/titin cap protein (T cap)            Mouse    Santa Cruz Biotechnology, clone G11, sc-25327
  Vimentin                                        Rabbit   Novus Bio (Littleton, CO, USA) / Bio-techne (Minneapolis, MN, USA), NBP1-31327

###### 

Qualitative summary of protein expression and organization as observed in this study (left column), and notes about the known pattern in the adult human heart as previously reported (right column).

  Protein                     Labeling and organization in hiPSC-CMs   Presence in normal adult ventricular cardiomyocytes
  --------------------------- ---------------------------------------- -----------------------------------------------------
  All actin                   +++                                      Yes
  Alpha smooth muscle actin   ++                                       No
  Beta-catenin                +++                                      Yes
  BIN-1                       ++                                       Yes
  Cardiac troponin-I          ++                                       Yes
  Cardiac troponin-T          +++                                      Yes
  CARP                        ++                                       Yes
  Connexin-43                 +++                                      Yes
  Myomesin                    +++                                      Yes
  EH-myomesin                 +++                                      No
  M-protein                   \+                                       Yes
  Myosin light chain 2a       ++                                       Yes, atrium
  Myosin light chain 2v       ++                                       Yes, ventricle
  SERCA2a                     ++                                       Yes
  Telethonin (T-cap)          \+                                       Yes
  Vimentin                    ++                                       No
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